drugset / Trial / NCT03255642

Efficacy and Safety of Melatonin and Clonazepam for IRBD

NCT03255642

RandomizedParallel-groupSingle-blindTreatment

Summary

This study aimed to evaluate influence of melatonin or clonazepam treatment on symptom and polysomnographic parameters in patients with idiopathic REM sleep behavior disorder.

Timeline

Start
2017-11-09
Primary completion
2020-12-01
Completion
2020-12-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clonazepam Small molecule 0.5 mg
Comparator Melatonin Small molecule 2 mg